Mark V. Anquillare Buys 2,500 Shares of TruBridge, Inc. (NASDAQ:TBRG) Stock

TruBridge, Inc. (NASDAQ:TBRG) Director Mark V. Anquillare purchased 2,500 shares of the stock in a transaction that occurred on Monday, November 25th. The stock was bought at an average cost of $16.81 per share, with a total value of $42,025.00. Following the completion of the transaction, the director now directly owns 17,178 shares in the company, valued at $288,762.18. The trade was a 17.03 % increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.

TruBridge Stock Up 4.8 %

TBRG stock opened at $17.75 on Thursday. The company has a debt-to-equity ratio of 1.00, a quick ratio of 1.78 and a current ratio of 1.80. The company has a market capitalization of $265.01 million, a price-to-earnings ratio of -4.34, a PEG ratio of 37.62 and a beta of 0.61. TruBridge, Inc. has a fifty-two week low of $7.55 and a fifty-two week high of $17.79. The stock has a fifty day moving average of $13.43 and a 200-day moving average of $11.78.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently made changes to their positions in TBRG. Barclays PLC bought a new position in TruBridge in the 3rd quarter worth about $150,000. Geode Capital Management LLC bought a new position in TruBridge in the 3rd quarter worth about $1,747,000. XTX Topco Ltd bought a new position in TruBridge in the 3rd quarter worth about $154,000. Jane Street Group LLC purchased a new stake in shares of TruBridge in the 3rd quarter valued at about $400,000. Finally, State Street Corp purchased a new stake in shares of TruBridge in the 3rd quarter valued at about $829,000. Institutional investors own 88.64% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of brokerages have issued reports on TBRG. Stephens upped their price objective on TruBridge from $13.00 to $17.00 and gave the company an “equal weight” rating in a research note on Wednesday, November 20th. Royal Bank of Canada restated an “outperform” rating and issued a $14.00 price objective on shares of TruBridge in a research note on Tuesday, September 17th. Cantor Fitzgerald restated an “overweight” rating and issued a $13.00 price objective on shares of TruBridge in a research note on Friday, October 4th. Finally, Barclays increased their price target on TruBridge from $10.00 to $14.00 and gave the stock an “equal weight” rating in a research note on Monday, November 11th.

About TruBridge

TruBridge, Inc provides healthcare solutions and services for community hospitals, clinics, and other healthcare systems in the United States and internationally. The company operates in three segments: Revenue Cycle Management (RCM), Electronic Health Record (HER), and Patient Engagement. It focuses on providing RCM solutions for care settings, regardless of primary healthcare information solutions provider along with business management, consulting, managed IT services, and analytics and business intelligence.